Detalhe da pesquisa
1.
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
Clin Cancer Res
; 29(5): 878-887, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534523